Gov. Andy Beshear is highlighting a new investment in Kentucky’s workforce development initiatives. According to a release by the governor’s office on Thursday, over 11,700 Kentuckians will receive ...

Gov. Andy Beshear highlighted new investment in Kentucky’s workforce development initiatives to further maintain and advance ...

Short interest in Amneal Pharmaceuticals Inc (NASDAQ:AMRX) increased during the last reporting period, rising from 4.89M to 6.10M. This put 3.03% of the company's publicly available shares short.

Revenue: $695 million, a growth of 5% year-over-year. Adjusted EBITDA: $170 million, an increase of 12%. Adjusted EPS: $0.21, representing a 50% growth. Gross Margin: 43.1%, up 120 basis points year-o ...

Amneal Pharmaceuticals reported its first-quarter 2025 earnings, surpassing analysts’ expectations with an adjusted EPS of $0.21 against the forecasted $0.15. Revenue came in at $695 million, slightly ...

Revenue, cost of goods sold, and gross profit from the sale of Amneal products by AvKARE were included in our Affordable Medicines segment.

Investing.com — Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)周五公布的第一季度盈利超出预期，但营收未能达到分析师预估。 该公司股价在财报发布后的盘前交易中下跌-3.10%。 这家仿制药制造商2025财年第一季度调整后每股收益为$0.21，超过了$0.15的市场一致预期。然而 ...

Amneal Pharmaceuticals (AMRX) reported $695.42 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 5.5%. EPS of $0.21 for the same period compares to $0. ...

BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Amneal Pharmaceuticals, Inc. (AMRX) on Friday reported first-quarter net income of $12.2 million, after reporting a loss in the same period a ...